A carregar...

Cetuximab Augments Cytotoxicity with Poly (ADP-Ribose) Polymerase Inhibition in Head and Neck Cancer

Overexpression of the epidermal growth factor receptor (EGFR) is a hallmark of head and neck cancers and confers increased resistance and inferior survival rates. Despite targeted agents against EGFR, such as cetuximab (C225), almost half of treated patients fail this therapy, necessitating novel th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Nowsheen, Somaira, Bonner, James A., LoBuglio, Albert F., Trummell, Hoa, Whitley, Alexander C., Dobelbower, Michael C., Yang, Eddy S.
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3166164/
https://ncbi.nlm.nih.gov/pubmed/21912620
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0024148
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!